The Food & Drug Administration has asked the United States Pharmacopeia to develop more sensitive tests to detect contamination in heparin products.
New heparin monographs should be coming from the
Q&A: How Specific GLP-1s Impact Different Patient Populations | ASHP Midyear
Jennifer Clements, PharmD, BCACP, BC-ADM, BCPS, CDCES, FADCES, FCCP, discussed current GLP-1 medication offerings and how each impacts patients differently.